Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may predict rectal cancer treatment success

NCT ID NCT07393048

Recruiting now Knowledge-focused Sponsor: Beijing Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test that looks for tiny bits of cancer DNA to see if it can predict how well treatment works for people with advanced rectal cancer. Researchers will collect blood and tissue samples from 60 patients before, during, and after treatment. The goal is to create a model that helps doctors know early if the cancer is responding, but this study does not offer a new treatment or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED RECTAL CANCER (LARC)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Friendship Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100050, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.